Complete report is available @ http://www.rnrmarketresearch.com/parkinsons-disease-therapeutics-market-to-2019-pipeline-shows-shift-towards-long-term-disease-management-market-report.html .
The Latest pharma report – “Parkinson’s Disease Therapeutics Market to 2019 – Pipeline Shows Shift towards Long Term Disease Management”. The Parkinson’s disease (PD) market is dominated by symptomatic treatments targeting functional impairment in PD. Levodopa has remained the gold standard treatment for almost 40 years and has significantly improved patient quality of life.
